Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia
- 1 May 1989
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 31 (1) , 32-35
- https://doi.org/10.1002/ajh.2830310106
Abstract
The intravenous infusion of 1‐deamino‐8‐D‐arginine vasopressin (DDAVP) is used as a nontransfusional form of treatment in patients with congenital and acquired bleeding disorders, including patients with uremia associated with prolonged bleeding times. Since uremic patients experience minor bleeding episodes that might be self‐managed at home (particularly epistaxis, gingival bleeding, and menorrhagia), we carried out a double‐blind, placebo‐controlled crossover study in nine uremics to evaluate whether the prolonged bleeding times could be shortened by subcutaneous injections of DDAVP. One hour after administration, the bleeding time was significantly shortened (P < .01) and became normal in seven of nine patients. After 4 hr, the bleeding time was still shorter than baseline (P < .01), but in only three patients was it still normal. There was no significant bleeding time change after placebo. When the same patients were treated with the same dose of DDAVP infused intravenously, the bleeding times were not significantly different from those measured after subcutaneous administration. Hence, subcutaneous DDAVP is an alternative method for short‐term shortening of the bleeding time in uremia, at least as effective as intravenous DDAVP but with the possibility of self‐administration by the patients at home.Keywords
This publication has 8 references indexed in Scilit:
- BLEEDING IN RENAL FAILUREThe Lancet, 1988
- Hemodynamic and Coagulation Responses to 1-Desamino[8-D-Arginine] Vasopressin in Patients with Congenital Nephrogenic Diabetes InsipidusNew England Journal of Medicine, 1988
- Comparison Between Subcutaneous and Intravenous DDAVP in Mild and Moderate Hemophilia AThrombosis and Haemostasis, 1985
- The subcutaneous administration of the vasopressin analogue 1-desamino-8-D-arginine vasopressin in patients with von Willebrand's disease and hemophiliaJournal of Molecular Medicine, 1984
- Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaNew England Journal of Medicine, 1983
- Immunoradiometric Assay of Factor VIII Related Antigen, with Observations in 32 Patients with von Willebrand's DiseaseBritish Journal of Haematology, 1976
- Electroimmuno AssayScandinavian Journal of Clinical and Laboratory Investigation, 1972